These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22283816)

  • 1. Natural products as leads for tuberculosis drug development.
    Salomon CE; Schmidt LE
    Curr Top Med Chem; 2012; 12(7):735-65. PubMed ID: 22283816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitubercular Marine Natural Products.
    Wang L; Wang J; Liu J; Liu Y
    Curr Med Chem; 2018; 25(20):2304-2328. PubMed ID: 28088903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents.
    Peng X; Zeng Z; Hassan S; Xue Y
    Bioorg Chem; 2024 Oct; 151():107699. PubMed ID: 39128242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target discovery focused approaches to overcome bottlenecks in the exploitation of antimycobacterial natural products.
    Baptista R; Bhowmick S; Nash RJ; Baillie L; Mur LA
    Future Med Chem; 2018 Apr; 10(7):811-822. PubMed ID: 29569936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
    Mutai P; Pavadai E; Wiid I; Ngwane A; Baker B; Chibale K
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2510-3. PubMed ID: 25977095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of natural and synthetic coumarin derivatives against
    Pires CT; Scodro RB; Cortez DA; Brenzan MA; Siqueira VL; Caleffi-Ferracioli KR; Vieira LC; Monteiro JL; Corrêa AG; Cardoso RF
    Future Med Chem; 2020 Sep; 12(17):1533-1546. PubMed ID: 32820960
    [No Abstract]   [Full Text] [Related]  

  • 8. New perspectives on natural products in TB drug research.
    Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
    Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico comparison of antimycobacterial natural products with known antituberculosis drugs.
    Espinoza-Moraga M; Njuguna NM; Mugumbate G; Caballero J; Chibale K
    J Chem Inf Model; 2013 Mar; 53(3):649-60. PubMed ID: 23410241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
    Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
    Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural antimicrobial peptides against Mycobacterium tuberculosis.
    Abedinzadeh M; Gaeini M; Sardari S
    J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting natural product value, an exploration of anti-TB drug space.
    Dashti Y; Grkovic T; Quinn RJ
    Nat Prod Rep; 2014 Aug; 31(8):990-8. PubMed ID: 24881816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development against tuberculosis: Impact of alkaloids.
    Mishra SK; Tripathi G; Kishore N; Singh RK; Singh A; Tiwari VK
    Eur J Med Chem; 2017 Sep; 137():504-544. PubMed ID: 28628823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model to predict anti-tuberculosis activity: value proposition for marine microorganisms.
    Liu M; Grkovic T; Zhang L; Liu X; Quinn RJ
    J Antibiot (Tokyo); 2016 Aug; 69(8):594-9. PubMed ID: 27406906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of new anti-tuberculosis drugs: the strategy of unconventional microbial culture and silencing gene activation].
    Teng T; Xie L; Xie J
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1306-1315. PubMed ID: 30152216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
    Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
    Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Anti-Tuberculosis Activity Behaviour of Natural Kaurane and Trachylobane Diterpenes Compared with Structural Properties Obtained by Theoretical Calculations.
    Soares ACF; Cabral MMW; Martins CHG; Ferreira AE; Bergamo PAS; Omosa LK; Midiwo JO; Parreira RLT; Heleno VCG
    Nat Prod Commun; 2017 May; 12(5):763-769. PubMed ID: 30496662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products, small molecules, and genetics in tuberculosis drug development.
    Gutierrez-Lugo MT; Bewley CA
    J Med Chem; 2008 May; 51(9):2606-12. PubMed ID: 18393405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.